MISSISSAUGA, ON, Nov. 16, 2015 /CNW/ - Cipher Pharmaceuticals Inc. (NASDAQ: CPHR; TSX:CPH) ("Cipher" or "the Company") today announced that Shawn Patrick O'Brien, President and Chief Executive Officer, will be presenting at the TD Securities 2015 Technology & Healthcare Conference in Toronto, Ontario on Friday, November 20, 2015 at 9:00AM ET.
About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals (NASDAQ: CPHR; TSX:CPH) is a rapidly growing specialty pharmaceutical dermatology company with a diversified portfolio of commercial-stage products with the goal of becoming the most customer-centric dermatology company in North America.
Cipher has completed seven transactions in 2015, including the acquisition of Innocutis and its nine branded dermatology products, to build its U.S. commercial presence, expand its Canadian dermatology franchise and broaden its pipeline. Cipher is well-capitalized to drive long-term, sustained earnings growth by leveraging its proven clinical development capabilities and efficient commercial execution. For more information, visit www.cipherpharma.com.
SOURCE Cipher Pharmaceuticals Inc.
For further information: Investors: In Canada: Lawrence Chamberlain, NATIONAL Equicom, (416) 848-1457, firstname.lastname@example.org; In the United States: Thomas Hoffmann, The Trout Group LLC, (646) 378-2931, email@example.com; Media: Mike Beyer, Sam Brown Inc., (312) 961-2502, firstname.lastname@example.org